Walker JH, Boustead CM, Koster JJ, Bewley M., Waller DAAnnexin V, a calcium-dependent phospholipid-binding protein. Biochem Soc Trans1992; 20: 828-33.
2.
Tait JF, Sakata M., McMullen B. et al. Placental anticoagulant protein proteins: isolation and comparative characterization of four members of the lipocortin family. Biochemistry1988; 27: 6268-76.
3.
Reutelingsperger Cpm, Horstra G., Henker HCIsolation and partial purification of a novel anticoagulant from arteries of human umbilical cord . Eur J Biochem1990; 151: 174-9.
4.
Flaherty MJ, West S., Heimark R.Placental anticoagulant protein. I. Measurement in extracellular fluids and cells of the haemostatic system. J Lab Clin Med1990; 115: 174-9.
5.
Christmas P. , Callaway J., Fallon J., Jones J., Haigler HTSelective secretion of annexin I, a protein without a signal sequence, by the human prostate gland . J Biol Chem1991; 266: 2499-507.
6.
Reutelingsperger Cpm, Kop Jmm, Horsntra G. et al. Purification and characterization of a novel protein from bovine aorta that inhibits coagulation . Eur J Biochem1988; 1973: 171-8.
7.
Tait JF, Gibson D., Kujikawa K.Phospholipid binding properties of human placental anticoagulant protein I, a member of the lipocortin family. J Biol Chem1989; 264: 7944-9.
8.
Kondo S., Naguchi M., Funakoshi T. et al. Inhibition of human factor VIIa-tissue factor activity by placental anticoagulant protein. Thromb Res1987; 48: 449-59.
9.
Triplett DA, Brandt JT, Musgrave KA et al. The relationship between lupus anticoagulants and antibodies to phospholipid. JAMA1988; 259: 550-4.
10.
Thiagrajan P., Shapiro S., DeMarco L.Monoclonal immunoglobulin M lambda coagulation inhibitor with phospholipid specificity: mechanism of a lupus anticoagulant . J Clin Invest1980 ; 66: 397-405.
11.
Pengo V., Thiagarajan P., Shapiro S.Immunological specificity and mechanism of action of IgG lupus anticoagulants . Blood1987; 70: 69-76.
12.
Rosove MH, Brewer Pmc, Runge A. et al. Simultaneous lupus anticoagulant and anticardiolipin assays and clinical detection of antiphospholipids. Am J Hematol1989; 32: 148-9.
13.
Violi F., Valesini G., Ferri D. et al. Anticoagulant activity of anticardiolipin antibodies. Thromb Res1986; 44: 543-7.
14.
Sammaritano LR , Gharavi AE, Soberano C., Levy RA, Lockshin MDPhospholipid binding of antiphospholipid antibodies and placental anticoagulant protein . J Clin Immunol1992; 12: 27-35.
15.
Calandri C. , Rand JHAnticardiolipin antibodies block placental anticoagulant protein activity. Clin res1990 ; 38: 427 (abstract).
16.
Gharavi AE, Harris EN, Asherson RA et al. Anticardiolipin antibodies: isotype distribution and phospholipid specificity. Ann Rheum Dis1987; 46: 1-6.
17.
Green FA, Costello PBDivalent cation effects on the binding of human anti-phospholipid antibodies . Biochim Biophys Acta1987; 896: 47-51.
18.
Romisch J., Schorlemmer U., Fickenscher K. et al. Anticoagulant properties of placenta protein 4 (annexin V). Thromb Res1988; 52: 641-8.
19.
McNeil HP, Krilis SA, Chesterman CNPurification of antiphospholipid antibodies using a new affinity method . Thromb Res1988; 52: 641-8.
20.
McNeil HP, Simpson RJ, Chesterman CN, Krillis SAAntiphospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta2-glycoprotein 1 (apolipoprotein H). Proc Natl Acad Sci USA1990; 87: 4210-4.
21.
LaRosa L., Meroni PL, Tincani A. et al. Beta-2 glycoprotein I and placental anticoagulant protein I in placentae from patients with antiphospholipid syndrome. J Rheum (in press).
22.
Rand JH, Wu XX, Namelson Y., Lockwood CJDeficiency of annexin V (placental anticoagulant protein I) on the surfaces of placental villi of women with antiphospholipid antibodies and recurrent abortion. Thromb Hemost1993; 69: 953.
